Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.
This is a summary aggregated from Dark Reading. Read the complete article on the original site:
Read full article at Dark Reading
